Please Wait...

ROI Initiative: A Technology Solution for Investigator Payments

Managing investigator payments faces specific, well-known challenges. Current systems are fragmented and manual, and in most cases are not transactional or financial-based.

The result of continuing with current processes is the inability to manage the complexity of the contract and budget terms that are negotiated and paid throughout the course of a clinical trial. Current document management systems (e.g., CTMS and other homegrown systems) are based on non-financial system information that doesn’t manage or account for the accuracy of payments made.

Additionally, routine data monitoring activity does not always include time or cost for re-monitoring efforts related to past payment activity (e.g., monitors do not evaluate past payments that would be impacted by changed data). This effort would require an additional burden to operational personnel to perform this type of activity, resulting in higher costs for the clients. Not to mention that the monitoring and re-monitoring efforts would delay the timeliness of completing the site monitoring process. This further illustrates that payment automation is a critical piece in the overall drug development space, as it impacts all areas of the clinical trial execution process.

An automated system for payments can increase efficiency, accuracy, productivity and scalability for your clinical trials. Completing an ROI evaluation can help your team determine the benefits of switching to an automated payments solution. We've put together a guide to help you go through an ROI evaluation, including ways to measure benefits as well as how to do a cost analysis.

If you're interested in learning more about how an automated investigator payments system can help your company, feel free to send us a message; we'd be happy to provide you with more information or set up a demo of our products.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Bioclinica is divided into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging and Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Biomarker Laboratory. Our eHealth segment comprises an eClinical Solutions Division along with Safety and Regulatory Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.

RT @lauren_chazal: Talking about metrics at MAGI East! @bioclinica #magieast2017 #magi17 https://t.co/vfsvbqbMnF
bioclinica (10 hours ago)
We have an incredibly experienced and motivated team focused on accelerating our ability to do what’s... https://t.co/HjjLpn7aAN
bioclinica (12 hours ago)
Industry latest via CenterWatch News Online https://t.co/hgyMUAL1oZ
bioclinica (15 hours ago)
RT @lauren_chazal: Envisioning e-research in 2020 #magi2017 @bioclinica https://t.co/SOvp0Cttia
bioclinica (15 hours ago)
[blog] A primer on #Biomarkers in #ClinicalResearch https://t.co/3rmy3rnKFb
bioclinica (3 days ago)
RT @ACRPDC: Happy #clinicaltrialsday! Join the celebration by telling us what you are doing as a #clinicalresearch professional. https://t.…
bioclinica (3 days ago)

Latest Blogs: